Comprehensive mapping of immune perturbations associated with severe COVID-19
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Profound plasmablast expansion, innate cell modulation, and T cell activation are defining features of severe COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We believe that the features described herein may help to identify the immunopathology of similar illnesses, such as irAEs and CRS due to other immunotherapies (e.g. checkpoint inhibitors, CAR-T-cells) or COVID-19 [4, 18, 19], and to inform discussions on the type and length of clinical and immune monitoring warranted in such patients.”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical–pathologic correlation in these individuals resulted in valuable observations that may be instructive in understanding mechanisms of immune-induced pathologies, including those of checkpoint inhibitors, CAR-T cells, and infections such as COVID-19, known to target mucosal tissues and cause severe CRS [1, 5, 8, 18, 19].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“suggesting the lung as a source for the elevated plasma levels of type I IFNs early on infection”
From COVID-19 and the human innate immune system (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ineffective IFN innate immunity has been strongly associated with failure to control a primary SARS-CoV-2 infection and a high risk of fatal COVID-19, accompanied by innate cell immunopathology and a plasma cytokine signature of elevated CXCL10, interleukin (IL)-6, and IL-8 in many studies (Aid et al., 2020; Kuri-Cervantes et al., 2020; Li et al., 2020b; Lucas et al., 2020; Radermecker et al., 202”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“particularly observation of elevated frequencies of neutrophils (the most common cell type of the innate immune system) in blood (Kuri-Cervantes et al., 2020), and massive numbers of neutrophils in lungs, associated with severe, end-stage COVID-19 disease (Li et al., 2020b; Liao et al., 2020; Radermecker et al., 2020; Schurink et al., 2020). In contrast, end-stage disease is not generally”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Kuri-Cervantes et al., 2020
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 161
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,296
Binary Codes capable of currecting deletions, insertions, and reversals
Levenshtein, V. I. (1965) · Soviet physics. Doklady · Cited by 14,807
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Research works printed but not linked: 2
- WHO Novel Coronavirus 2019 Reports (World Health Organization 2020) vol. 2020.
- 10.1146/annurev.iy.13.040195.001015 · doi:10.1146/annurev.iy.13.040195.001015 · Paper page
Cited by
Items 601–700 of 761
Re, A. D., Franzin, S. B., Lu, J., Palenca, I., Zilli, A., Pepi, F., Troiani, A., Seguella, L., Pesce, M., Esposito, G., et al. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00167-x · Cited by 3
Characteristic Immune Dynamics in COVID-19 Patients with Cardiac Dysfunction
Gonzalez, F. A., Ângelo‐Dias, M., Martins, C. G., Gomes, R. M., Blanco, J. B., Fernandes, A., Borrego, L. M., & EchoCrit Group (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071880 · Cited by 3
Lagedal, R., Eriksson, O., Sörman, A., Huckriede, J., Kristensen, B. W., Franzén, S., Larsson, A. O., Bergqvist, A., Alving, K., Forslund, A. H., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123419 · Cited by 3
Avcu, G., Arslan, S. Y., Soylu, M., Bilen, N. M., Bal, Z. Ş., Çiçek, C., Kurugöl, Z., & Özkınay, F. (2022) · Viral Immunology · doi:10.1089/vim.2022.0089 · Cited by 3
Guo, Q., Zhao, Y., Li, J., Liu, J., Guo, X., Zhang, Z., Cao, L., Luo, Y., Bao, L., Wang, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.288704 · Cited by 3
Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral controlPreprint
Dong, T., Liu, G., Felce, S. L., Yao, X., Yin, Z., Fries, A., Mentzer, A. J., Dong, D., Wang, W., Dejnirattisai, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1317569/v1 · Cited by 4
Zhang, J., Meng, Y., Yang, M., Hao, W., Liu, J., Wu, L., Yu, X., Zhang, Y., Lin, B., Xie, C., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112141 · Cited by 2
Qin, Y., Li, C., Yuan, X., & Li, Z. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01315-y · Cited by 2
Luo, Y., Zhang, H., Tang, K., Wang, Y., Dong, H., Wei, Q., Shan, L., Tan, Y., Zhao, L., Shi, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202509259 · Cited by 2
Biological Plausibility Between Long-COVID and Periodontal Disease Development or Progression
Andriankaja, O. M., Whiteheart, S. W., & Mattos, M. B. D. A. (2025) · Biomedicines · doi:10.3390/biomedicines13123023 · Cited by 2
Petrea, C. L., Ciortea, D.-A., Gurău, G., Matei, M. N., Pleșea-Condratovici, A., Zaharia, A. E., (Ivașcu), C. B., Verga, G. I., & Berbece, S. I. (2026) · Biomedicines · doi:10.3390/biomedicines14020258 · Cited by 2
ПЕРЕВАГИ БІОРЕГУЛЯЦІЙНОГО ПІДХОДУ В ЛІКУВАННІ ТА РЕАБІЛІТАЦІЇ ПАЦІЄНТІВ З COVID-19. КЛІНІЧНИЙ ДОСВІД
Гулій, М. А., & Соловйова, В. С. (2022) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2021.v.i4.12801 · Cited by 2
Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19
Wu, K., Chao, Y., Weng, T.-F., & Li, J. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220926094730 · Cited by 2
Structural Modeling of Adaptive Immune Responses to Infection
Lusiany, T., Xu, Z., Saputri, D. S., Ismanto, H. S., Nazlica, S. A., & Standley, D. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_15 · Cited by 3
Casado‐Fernández, G., Corona, M., Torres, M., Sáez, A., Ramos-Martín, F., Manzanares, M., Vigón, L., Mateos, E., Pozo, F., Casas, I., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031947 · Cited by 2
Liu, X., Hua, L., Chu, J., Zhou, W., Jiang, F., Wang, L., Xu, F., Liu, M., Shi, J., & Xue, G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111788 · Cited by 2
Sustained immunological memory to SARS-CoV-2 antigens. Three years of observation
Afridonova, Z. E., Топтыгина, А. П., & Semikina, E. L. (2024) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-sim-17596 · Cited by 2
Data mining antibody sequences for database searching in bottom-up proteomics
Trinh, T. X., Freitag, R., Krawczyk, K., & Schwämmle, V. (2024) · ImmunoInformatics · doi:10.1016/j.immuno.2024.100042 · Cited by 2
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients
Sakakibara, S., Liu, Y., Ishikawa, M., Edahiro, R., Shirai, Y., Haruna, S., Hussien, M. A. E., Xu, Z., Li, S., Yamaguchi, Y., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402774 · Cited by 2
Trulioff, A. S., Borisov, A. G., Кудрявцев, И. В., Lazanovich, V. A., & Savchenko, A. A. (2024) · Medical academic journal · doi:10.17816/maj634763 · Cited by 2
Mining the Antibody Repertoire for Solutions to SARS-CoV-2
Meng, W., Rosenfeld, A. M., & Prak, E. T. L. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.09.010 · Cited by 2
Self-citationRostam, S. R. K., Shekhany, K. A. M., & Smail, H. O. (2020) · BIOVALENTIA Biological Research Journal · doi:10.24233/biov.6.2.2020.180 · Cited by 2
SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
Ahmad, R. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i5.55398 · Cited by 2
The Curious Case of Earthworms and COVID-19
Scott-Fordsmand, J. J., & Amorim, M. J. B. (2021) · Biology · doi:10.3390/biology10101043 · Cited by 3
Impact of low eGFR on the immune response against COVID-19
Blazquez‐Navarro, A., Mittmann, L., Thieme, C. J., Anft, M., Paniskaki, K., Doevelaar, A., Seibert, F. S., Hoelzer, B., Konik, M., Berger, M. M., et al. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01374-1 · Cited by 2
Jiménez‐Cortegana, C., Salamanca, E., Carrión, N. P., Sánchez-Jiménez, F., Pérez‐Pérez, A., Vilariño‐García, T., Fuentes, S., Pérez, S. M., Jiménez, M., Toribio, R. G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1266659 · Cited by 3
Chirmule, N. B., Nair, P., Desai, B., Khare, R., Nerurkar, V. R., & Gaur, A. (2021) · medRxiv · doi:10.1101/2021.04.01.21254804 · Cited by 2
Xin, X., Yao, W., Zhang, Z., Yang, X., Li, S., Zhu, Y. Y., Zhang, C., Zhang, L., Huang, H., Dong, T., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08607-z · Cited by 1
SEDEEQ, Z. K., SAMADZADE, R., Dağı, H. T., Çelik, J. B., Ural, O., & Fındık, D. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_83 · Cited by 1
Wang, D., Shen, Y., Wu, J., Li, Y., Ma, K., Jiang, G., Li, X., Qin, H., Chen, K., Wang, M., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119951 · Cited by 1
Schniederova, M., Bobčáková, A., Grendár, M., Markocsy, A., Čereš, A., Cibulka, M., Dobrota, D., & Jeseňák, M. (2025) · Medicina · doi:10.3390/medicina61020189 · Cited by 1
Heterogeneity and longitudinal transcriptomic characteristics of Tregs in COVID-19 patients
Wen, Y., Zhao, J., & Zhang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548173 · Cited by 1
Putri, D. U., Chen, M.-C., Weng, C., Kuo, H., Lee, C., & Han, C. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.07.004 · Cited by 1
Pedreño-López, N., Tarrés-Freixas, F., Usai, C., Regué, D. R., Benet, S., Ainsua‐Enrich, E., Carabelli, J., Pradenas, E., Ávila‐Nieto, C., Roca, N., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-09034-3 · Cited by 1
Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumonia
Yasuda, K., Aoki, J., Tanaka, K., Shichinohe, S., Ono, C., Vandenbon, A., Ohara, D., Muramoto, Y., Li, S., Motooka, D., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013969 · Cited by 1
Motaghi, M., Ghaffari, K., Mansori, M., & Ghasemi, A. (2026) · Health Science Reports · doi:10.1002/hsr2.71945 · Cited by 1
Araújo-Santos, T., Tavares, N. M., & Mengel, J. (2020) · EDUFBA eBooks · doi:10.9771/9786556300443.005 · Cited by 1
Tv, M. (2022) · Immunology and Allergy Science and Practice · doi:10.37321/immunology.2021.4-04 · Cited by 1
Adıgüzel, Y., & Shoenfeld, Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00017-7 · Cited by 1
(2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.312372 · Cited by 1
Tariq, M. J., Noraldeen, M. Y., & Al-kadhi, N. A. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_171_22 · Cited by 1
Sato, T., Takenaka, Y., & Takeuchi, M. (2024) · Vaccines · doi:10.3390/vaccines12080878 · Cited by 1
Sun, Y., Wang, H., Wang, H., Cai, J., Yuan, G., Zhang, H., Zhao, J., Xue, Q., Jiang, X., Huang, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136183 · Cited by 1
RetractedOliva‐Ariza, G., Criado, I., Fuentes‐Herrero, B., Carbonell, C., Sánchez-Gallego, J. I., López‐Bernús, A., Gutiérrez, M. L., Rolo-Ramírez, A., Bernal‐Ribes, M., Almenara-Morales, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020681 · Cited by 1
Pan, X., Zhu, M., Huang, G., Li, X., Liao, J., Huang, S., & Wang, W. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09333-9 · Cited by 1
Yao, W., Li, B., Jiang, Y., Yuan, Q.-Y., Wu, W., Hou, R., Qi, Q., Dong, H., Zhang, Y., & Zhang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1594373 · Cited by 1
Are the Guidelines for Surgical Dental Cares Suitable for COVID-19 Pandemic?
Barenghi, L., Barenghi, A., Giannì, A. B., & Spadari, F. (2020) · Dental Research and Oral Health · doi:10.26502/droh.0030 · Cited by 1
Immunological Subpopulations Within Critically Ill COVID-19 Patients
Wilson, J., & Shankar‐Hari, M. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.023 · Cited by 1
Editorial: COVID-19 immunology and organ transplantation
Bery, A. I., Kulkarni, H. S., & Kreisel, D. (2021) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000862 · Cited by 1
Immune responses to SARS-CoV-2 in the lung
Arunachalam, P. S. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217231 · Cited by 1
Khromova, E. A., Костинов, М. П., Skhodova, S. A., Osiptsov, V. N., Bisheva, I. V., Пахомов, Д. В., Kurbatova, E. A., Альбертовна, Х. А., Kryukova, N. O., & Николаевич, Ш. М. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-coi-2852 · Cited by 2
SARS-CoV-2 B cell receptor signatures in at-risk populations
Flyak, A. I. (2020) · Journal of Clinical Investigation · doi:10.1172/jci144685
COVID-19 hastalığının immünopatolojisi ve immünolojisindeki güncel veriler
Azkur, D., & Azkur, A. K. (2020) · Eurasian journal of veterinary sciences · doi:10.15312/eurasianjvetsci.2020.290
Expanding the toolbox to combat a pandemic
Prockop, S. E. (2020) · Blood · doi:10.1182/blood.2020009408
Gating strategy for plasmablast enumeration after hepatitis B vaccination
Byazrova, M. G., Топтыгина, А. П., Mitina, T. A., & Filatov, A. V. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-gsf-2066
Lim, J., Puan, K. J., Wang, L. W., Teng, K. W. W., Loh, C. Y., Tan, K. P., Carissimo, G., Chan, Y., Poh, C. M., Lee, C. Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.10.430668
Long-term and short-term immunity to SARS-CoV-2: why it matters
Zaunders, J., & Phetsouphanh, C. (2021) · Microbiology Australia · doi:10.1071/ma21010
Corrigendum to : Therapeutics for COVID-19: established and in development
Singh, K. P., Sasadeusz, J. J., Lewin, S. R., & Audsley, J. (2021) · Microbiology Australia · doi:10.1071/ma20058_co · Cited by 1
Liu, Z., Donart-Gomez, A., Weldon, C., Senutovitch, N., & O’Rourke, J. P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97304
Adıgüzel, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.28.428642
Kedzierska, K., Habel, J. R., Chua, B. Y. L., Kedzierski, Ł., Selva, K. J., Damelang, T., Haycroft, E. R., Nguyen, T. H. O., Koay, H., Nicholson, S. R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-745648/v1
Byazrova, M. G., Kulemzin, S. V., Astakhova, E. A., Николаевна, Б. Т., Efimov, G. A., Chikaev, A. N., Kolotygin, I. O., Gorchakov, A. A., Taranin, A. V., & Filatov, A. V. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3918293
Immunotherapy in the Treatment of COVID-19
Михайловна, М. А., Starshinova, A. A., Kudryavtsev, I. V., Dovgalyuk, I. F., Zinchenko, Y. S., & Kudlay, D. A. (2021) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2021-20-3-158-168 · Cited by 1
ORGANIZATION FOR MEDICAL DEFENSE.
Larkey, S. V. (1941) · PubMed · Cited by 1
Vitamin D Reduces Covid-19 Mortality and Serious Illness: An Integrated Approach to EvidencePreprint
King, E. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/95jsd
COVID-19 hastalarında Hemofagositik Sendrom Tanısında Potansiyel Biyobelirteçler
Boral, B. (2022) · İstanbul Kanuni Sultan Süleyman Tıp Dergisi · doi:10.14744/iksstd.2021.78095
Atanasov, P. Y., Ivanova, S. A., Kobakova, Y. A., Moneva-Sakelarieva, M. G., Obreshkova, D. P., Petkova, V. B., & Yordanova-Laleva, P. (2022) · Pharmacia · doi:10.3897/pharmacia.69.e81063
(2020) · Microbiology Australia · doi:10.1071/mav41n4
Habel, J. R., Chua, B. Y. L., Kedzierski, Ł., Selva, K. J., Damelang, T., Haycroft, E. R., Nguyen, T. H. O., Koay, H., Nicholson, S. R., McQuilten, H. A., et al. (2021) · medRxiv · doi:10.1101/2021.08.21.21262399
(2021) · Microbiology Australia · doi:10.1071/mav42n1
РОЛЬ КЛЕТОЧНОГО ЗВЕНА ИММУНИТЕТА В ФОРМИРОВАНИИ ИММУННОГО ОТВЕТА ПРИ КОРОНАВИРУСНЫХ ИНФЕКЦИЯХPreprint
Ia, I., Omelchenko, N. D., Filippenko, A. V., Trufanova, A. A., & Носков, А. К. (2021) · doi:10.21055/preprints-3111935
PROSPECTS FOR IMMUNOTHERAPY TREATMENT AGAINST COVID-19 INFECTION
KUKULADZE, N., & BAKHUTASHVILI, A. (2022) · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · doi:10.52340/jecm.2022.06.05.07
Saha, A., Das, S., Biswas, D., Sain, B., Mitra, M., Chakraborty, R., Basu, S., Shamim, S., Mukherjee, A., Ghosh, D., et al. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.09.007
Agarwal, S. (2022) · Pharmaceutical Drug Regulatory Affairs Journal · doi:10.23880/pdraj-16000137
Yıldırım, D. İ. (2022) · Selçuk Tıp Dergisi · doi:10.30733/std.2022.01556
Níveis plasmáticos de HLA-G solúvel em pacientes com covid-19
Cordeiro, J. F. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2022.tde-10112022-150404
The Rationale Behind the Effectiveness of COVID-19 Vaccines and Associated Immunological Mechanisms
Khatib, S. E. (2022) · Turkish Journal of Immunology · doi:10.4274/tji.galenos.2022.55264
Chowdhury, S. R., Chakrabarty, S., Chakraborti, M., & Das, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85730-7.00009-6
Wallis, R. S., Srivastava, A. K., Wack, A., & Knirsch, C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00003-8
Respuesta inmunitaria anti-SARS-CoV-2: Infección Natural vs. Vacunación
Oropeza, M. J. P., Sanchez, S. R., Fuentes, C. S., Manrique, M. S., Rodríguez, I. V., & Escobar-Guevara, E. E. (2023) · Revista Digital de Postgrado · doi:10.37910/rdp.2023.12.1.e358
Comprehensive mapping of immune perturbations associated with Acute Gouty ArthritisPreprint
Zhong, L., Gong, Y., Li, W., Li, L., Yang, H., Huang, Y., Huang, L., Chen, Y., Wu, X., Huang, L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2939894/v1
Arons, E., Henry, K. N., Haas, C. J., Gould, M., Tsintolas, J., Mauter, J. T., Zhou, H., Burbelo, P. D., Cohen, J. I., & Kreitman, R. J. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29179
The Covid-19 and TB Syndemic: Differences and Similarities
Kaufmann, S. H. E., Sher, A., Sigal, A., & Sawitzki, B. (2023) · Frontiers research topics · doi:10.3389/978-2-8325-4116-6
Procoagulant Status and Fibrinolytic Activity in COVID-19 Patients during Illness and Convalescence
Beznoshchenco, O. S., Romanov, A. Y., Dolgushina, N. V., Gorodnova, E. A., Ivanets, T. Y., Львовна, Я. Е., Pyregov, A. V., Grachev, S. V., & Sukhikh, G. T. (2023) · Biomedicines · doi:10.3390/biomedicines12010042
Adıgüzel, Y., & Shoenfeld, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99130-8.00021-0 · Cited by 1
Comparative clinical investigation of blood profiling in COVID-19 patients
Kulshrestha, S., Raghav, A., Chadha, R., & Raghav, P. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95545-4.00006-2
Adıgüzel, Y., & Shoenfeld, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99130-8.00024-6
Gauthier, M. (2021) · theses.fr (ABES) · doi:10.70675/1e0dd91cz8aa7z43e9zb1bez0a9d143a5604 · Cited by 1
Gallais, F. (2022) · theses.fr (ABES) · doi:10.70675/e59d3115z0d3cz4706z95d7z5e5391695224
Additional file 1 of Anchor Clustering for million-scale immune repertoire sequencing data
Chang, H., Ashlock, D., Graether, S. P., & Keller, S. M. (2024) · Figshare · doi:10.6084/m9.figshare.25067253
Reizine, F. (2022) · theses.fr (ABES) · doi:10.70675/3c57db65z8cefz4785z931cz235b344278bc
Das, A., Wei, J., McKenzie, D. R., Snell, L. B., Sasidharan, S., Vantourout, P., Zlatareva, I., Merrick, B., Thomas, B., Adiga, V., et al. (2024) · medRxiv · doi:10.1101/2024.06.15.24308935
Costa, A. L. C. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-11042024-103009
Plasmablast response during acute SARS-CoV-2 infection
Byazrova, M. G., Sukhova, M. M., Mikhailov, A. A., ROMANOVA, A., Yusubaliyeva, G. M., & Filatov, A. V. (2024) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-prd-16670
Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2
Wojas‐Krawczyk, K., Krawczyk, P. A., Błach, J., Kucharczyk, T., Grenda, A., Krzyżanowska, N., Szklener, K., Horaczyńska-Wojtaś, A., Wójcik-Superczyńska, M., Chmielewska, I., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09772-5
COVID-19 in Cancer and Hematopoietic Stem Cell Transplant Recipients
Baluch, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-57369-9_12
Histological analysis of the spleen of rats immunized with SARS-CoV-2 S protein
Владимировна, Ф. К., Khramova, T., Terentiev, A., & Terentievа, O. S. (2024) · Russian Journal of Immunology · doi:10.46235/1028-7221-16599-hao
Bera, A., Chakraborty, K., & Bhattacharyya, A. (2020) · Journal of Applied Biochemistry & Laboratory Medicine · doi:10.5005/jablm-11031-01104
Metadata
- Authors
- Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., Kuthuru, O., Apostolidis, S. A., Bershaw, L., Dougherty, J., Greenplate, A. R., Pattekar, A., Kim, J., Han, N., Gouma, S., Weirick, M. E., Arevalo, C. P., Bolton, M. J., Goodwin, E. C., Anderson, E. M., Hensley, S. E., Jones, T. K., Mangalmurti, N. S., Luning Prak, E. T., Wherry, E. J., Meyer, N. J., & Betts, M. R.
- Affiliations
- University of Pennsylvania (US)
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Children's Hospital of Philadelphia (US)
- Hospital of the University of Pennsylvania (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Kuri-Cervantes, Leticia
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- ORCID
- Kuri-Cervantes, Leticia
- Pampena, Maria Betina
- Meng, Wenzhao
- Rosenfeld, Aaron M.
- Weisman, Ariel R.
- Agyekum, Roseline S.
- Mathew, Divij
- Baxter, Amy E.
- Vella, Laura A.
- Kuthuru, Oliva
- Apostolidis, Sokratis A.
- Bershaw, Luanne
- Dougherty, Jeanette
- Greenplate, Allison R.
- Pattekar, Ajinkya
- Kim, Justin
- Han, Nicholas
- Gouma, Sigrid
- Weirick, Madison E.
- Arevalo, Claudia P.
- Bolton, Marcus J.
- Anderson, Elizabeth M.
- Hensley, Scott E.
- Jones, Tiffanie K.
- Mangalmurti, Nilam S.
- Luning Prak, Eline T.
- Wherry, E. John
- Meyer, Nuala J.
- Betts, Michael R.
- Venue
- Science Immunology
- Published
- 2020-07-03
- Volume
- 5
- Issue
- 49
- ISSN
- 2470-9468 (ISSN-L)
- PMC
- PMC7402634
- OpenAlex
- W3042587425
- Cited by
- 723
- References
- 107
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 63 · 2023: 101 · 2022: 182 · 2021: 251 · 2020: 83
- FWCI
- 20.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL137006, HL137915, AI144288, P30-CA016520, AI105343, AI115712, AI117950, AI108545, AI082630, CA210944, T32 CA009140.)
- National Institute of Allergy and Infectious Diseases (AI136660)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- severe COVID-19, SARS-CoV-2, immune perturbation, hyperinflammation, T cell activation, innate lymphoid cells, granulocytes, neutrophil-to-lymphocyte ratio, prognostic factors, organ failure
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, Female, Humans, Immunity, Innate, Immunologic Memory, Lymphocyte Activation, Male, Middle Aged, Neutrophils, Pneumonia, Viral, T-Lymphocytes, B-Lymphocyte Subsets, Cytokines, Coronavirus Infections, Lymphocyte Count, Pandemics, Clonal Selection, Antigen-Mediated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.